Eisai Company, Ltd. (ESALY.PK) Completes Acquisition of AkaRx, Inc. and Continues Development of AKR-501 for Thrombocytopenia
1/7/2010 9:28:08 AM
More...
|
Japan's Eisai Company, Ltd. (ESALY.PK) (JOBS) to Buy US Drug Firm AkaRx, Inc. for $255 Million
12/18/2009 6:56:38 AM
More...
|
AkaRx, Inc. and MGI PHARMA, INC. (MOGN) Announce Closing of Development and License Agreement
10/11/2007 12:24:29 PM
More...
|
MGI PHARMA, INC. (MOGN) Buys Rights To AkaRx, Inc.'s Blood-Cell Disorder Drug: Upfront Payments of Up to $45 Million
8/28/2007 2:52:38 PM
More...
|